Arthritis & Rheumatic Diseases

Medicine & Life Sciences

1. Ankylosing Spondylitis 100%
2. Psoriatic Arthritis 50%
3. secukinumab 38%
4. Placebos 32%
5. Tumor Necrosis Factor Inhibitors 29%
6. Rheumatoid Arthritis 26%
7. golimumab 25%
8. ixekizumab 23%
9. Safety 21%
10. Rheumatology 20%
11. Therapeutics 17%
12. Systemic Lupus Erythematosus 17%
13. guselkumab 17%
14. HIV 16%
15. Psoriasis 15%
16. Interleukin-17 13%
17. Uveitis 12%
18. Antirheumatic Agents 12%
19. Inflammation 12%
20. India 11%
21. Arthritis 11%
22. Microbiota 11%
23. Rheumatologists 10%
24. T-Lymphocytes 10%
25. upadacitinib 9%
26. Joints 9%
27. Anterior Uveitis 8%
28. Baths 8%
29. Randomized Controlled Trials 8%
30. Tumor Necrosis Factor-alpha 8%
31. Gastrointestinal Microbiome 8%
32. Blau syndrome 8%
33. Cytokines 8%
34. HIV-1 8%
35. Fibromyalgia 8%
36. Quality of Life 7%
37. Patient Reported Outcome Measures 7%
38. Spine 6%
39. Signs and Symptoms 6%
40. Genes 6%
41. HIV Infections 6%
42. Sacroiliitis 6%
43. Tuberculosis 6%
44. Infections 6%
45. Back Pain 5%
46. Fatigue 5%
47. Pain 5%
48. Infliximab 5%
49. Biological Products 5%
50. Acquired Immunodeficiency Syndrome 5%
51. Spondylitis 5%
52. bimekizumab 5%
53. Sacroiliac Joint 5%
54. Systemic Scleroderma 5%
55. Vasculitis 5%
56. HLA-B27 Antigen 5%
57. Clinical Trials 5%
58. Opportunistic Infections 5%
59. Population 5%